A Study on Siddha Formulation Seedhobalathi Chooranam for Kuruthi Azhal Noi (Essential Hypertension)

Clinical Evaluation of Siddha Formulation Seedhobalathi Chooranam in the Management of Kuruthi Azhal Noi (Essential Hypertension) Among the Patients Attending Ayothidoss Pandithar Hospital, National Institute of Siddha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087168

Enrollment

Registered

2025-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Seedhobalathi Chooranam: 3 grams of Seedhobalathi Chooranam with milk twice a day after food for 48 days. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Stage I Hypertension according to Joint National Committee 8 guidelines

Exclusion criteria

Exclusion criteria: K/c/o liver diseases, kidney disease, hematopoietic disease, malignant tumor, cardiac diseases, cerebrovascular diseases, white collar hypertension. Patients who are taking anti-hypertensive medication

Design outcomes

Primary

Measure	Time frame
The changes in systolic and diastolic blood pressure will be assessed before and after treatment ( according to JNC 8 guidelines).Timepoint: 48 days	—

Secondary

Measure	Time frame
The quality of life in patients with hypertension through SF-36 questionnaire will be assessed before and after treatment.Timepoint: 48 days	—

Countries

India

Contacts

Public ContactDr H Vetha Merlin Kumar

National institute of siddha

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026